State of Wisconsin Investment Board
ZVRA icon

State of Wisconsin Investment Board’s Zevra Therapeutics ZVRA Stock Holding History

State of Wisconsin Investment Board’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$604K Buy
+64,857
New +$585K ﹤0.01% 1900
2025
Q4 		– Sell
-43,026
Closed -$409K – 2594
2025
Q3 		$409K Buy
+43,026
New +$432K ﹤0.01% 1984

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State of Wisconsin Investment Board's ZVRA Position: Q1 2026 in Review

State of Wisconsin Investment Board opened a new position in Zevra Therapeutics (ZVRA) in Q1 2026: 64,857 shares worth $604K. The stake represents ﹤0.01% of the portfolio and ranks #1900 among its holdings. This is a return to the name: State of Wisconsin Investment Board previously reported a position in ZVRA as recently as Q3 2025.

State of Wisconsin Investment Board first reported a position in ZVRA in Q3 2025 and has held it in 2 quarters since. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • State of Wisconsin Investment Board held 64,857 shares of Zevra Therapeutics worth $604K as of Q1 2026.
  • Zevra Therapeutics was a new State of Wisconsin Investment Board position in Q1 2026.
  • Zevra Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1900 holding.
  • State of Wisconsin Investment Board first reported a position in Zevra Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.